These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4571 related items for PubMed ID: 220273

  • 21. Enzymatic regulation of mast cell activation and secretion by adenylate cyclase and cyclic AMP-dependent protein kinases.
    Winslow CM, Austen KF.
    Fed Proc; 1982 Jan; 41(1):22-9. PubMed ID: 6173264
    [Abstract] [Full Text] [Related]

  • 22. Phosphorylation of regulatory subunit of type I cyclic AMP-dependent protein kinase: biphasic effects of cyclic AMP in intact S49 mouse lymphoma cells.
    Russell JL, Steinberg RA.
    J Cell Physiol; 1987 Feb; 130(2):207-13. PubMed ID: 3029147
    [Abstract] [Full Text] [Related]

  • 23. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells.
    Albert DA, Nodzenski E, Yim G, Kowalski J.
    J Cell Physiol; 1990 May; 143(2):251-6. PubMed ID: 2159014
    [Abstract] [Full Text] [Related]

  • 24. Multiple mechanisms of growth inhibition by cyclic AMP derivatives in rat GH1 pituitary cells: isolation of an adenylate cyclase-deficient variant.
    Martin TF, Ronning SA.
    J Cell Physiol; 1981 Nov; 109(2):289-97. PubMed ID: 6271795
    [Abstract] [Full Text] [Related]

  • 25. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA, Merlino G.
    Oncogene; 2002 Feb 07; 21(7):1000-8. PubMed ID: 11850817
    [Abstract] [Full Text] [Related]

  • 26. Cyclic adenosine 3':5'-monophosphate-dependent protein phosphorylation and the control of leukemia L1210 cell growth.
    Mednieks MI, Jungmann RA, DeWys WD.
    Cancer Res; 1982 Jul 07; 42(7):2742-7. PubMed ID: 6282449
    [Abstract] [Full Text] [Related]

  • 27. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C.
    Park HY, Russakovsky V, Ao Y, Fernandez E, Gilchrest BA.
    Exp Cell Res; 1996 Aug 25; 227(1):70-9. PubMed ID: 8806453
    [Abstract] [Full Text] [Related]

  • 28. Effects of prostaglandin D2 and theophylline on rat serosal mast cells: discordance between increased cellular levels of cyclic AMP and activation of cyclic AMP-dependent protein kinase.
    Holgate ST, Winslow CM, Lewis RA, Austen KF.
    J Immunol; 1981 Oct 25; 127(4):1530-3. PubMed ID: 6268708
    [Abstract] [Full Text] [Related]

  • 29. DNA-mediated transfer of cAMP resistance in CHO cells.
    Abraham I, Brill S, Chapman M, Hyde J, Gottesman M.
    J Cell Physiol; 1986 Apr 25; 127(1):89-94. PubMed ID: 3007543
    [Abstract] [Full Text] [Related]

  • 30. Strain activation of bovine aortic smooth muscle cell proliferation and alignment: study of strain dependency and the role of protein kinase A and C signaling pathways.
    Mills I, Cohen CR, Kamal K, Li G, Shin T, Du W, Sumpio BE.
    J Cell Physiol; 1997 Mar 25; 170(3):228-34. PubMed ID: 9066778
    [Abstract] [Full Text] [Related]

  • 31. Induction of the regulatory subunit of type I adenosine cyclic 3':5'-monophosphate-dependent protein kinase in differentiated N-18 mouse neuroblastoma cells.
    Liu AY, Chan T, Chen KY.
    Cancer Res; 1981 Nov 25; 41(11 Pt 1):4579-87. PubMed ID: 6272981
    [Abstract] [Full Text] [Related]

  • 32. Retinoic acid increases cyclic AMP-dependent protein kinase activity in murine melanoma cells.
    Ludwig KW, Lowey B, Niles RM.
    J Biol Chem; 1980 Jul 10; 255(13):5999-6002. PubMed ID: 6248511
    [Abstract] [Full Text] [Related]

  • 33. Type I cyclic AMP-dependent protein kinase as a positive effector of growth.
    Russell DH.
    Adv Cyclic Nucleotide Res; 1978 Jul 10; 9():493-506. PubMed ID: 208392
    [No Abstract] [Full Text] [Related]

  • 34. Studies on the Cloudman melanoma cell line as a model for the action of MSH.
    Pawelek JM.
    Yale J Biol Med; 1985 Jul 10; 58(6):571-8. PubMed ID: 3008451
    [Abstract] [Full Text] [Related]

  • 35. Characterization of the inhibitory effects of retinoids on the in vitro growth of two malignant murine melanomas.
    Lotan R, Giotta G, Nork E, Nicolson GL.
    J Natl Cancer Inst; 1978 May 10; 60(5):1035-41. PubMed ID: 205660
    [Abstract] [Full Text] [Related]

  • 36. Prostaglandin A1 and E1 inhibit the plating efficiency and proliferation of murine melanoma cells (Cloudman S-91) in soft agar.
    Bregman MD, Sander D, Meyskens FL.
    Biochem Biophys Res Commun; 1982 Feb 11; 104(3):1080-6. PubMed ID: 6280706
    [No Abstract] [Full Text] [Related]

  • 37. A mutant of 3T3 cells with cyclic AMP metabolism sensitive to temperature change.
    Willingham MC, Carchman RA, Pastan IH.
    Proc Natl Acad Sci U S A; 1973 Oct 11; 70(10):2906-10. PubMed ID: 4355372
    [Abstract] [Full Text] [Related]

  • 38. Effect of dicarboxylic acids on Harding-Passey and Cloudman S91 melanoma cells in tissue culture.
    Robins EJ, Breathnach AS, Ward BJ, Bhasin YP, Ethridge L, Nazzaro-Porro M, Passi S, Picardo M.
    J Invest Dermatol; 1985 Sep 11; 85(3):216-21. PubMed ID: 4031537
    [Abstract] [Full Text] [Related]

  • 39. Defect of insulin receptor in insulin-resistant variants of Cloudman S91 mouse melanoma cells.
    Slominski A, McNeely T, Pawelek J.
    Melanoma Res; 1992 Jul 11; 2(2):115-22. PubMed ID: 1643430
    [Abstract] [Full Text] [Related]

  • 40. Survival of Cloudman mouse melanoma cells after irradiation by solar wavelengths of light.
    Cieszka K, Hill HZ, Xin P, Azure M, Hill GJ, Meyenhofer MF, Boissy RE, Mitchell DL.
    Pigment Cell Res; 1997 Aug 11; 10(4):193-200. PubMed ID: 9263325
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 229.